Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study

Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study

Objective: To compare the efficacy and safety of the novel SVILE regimen with the P-GemOx regimen in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type (ND-ENKTL). Methods: From April 2015 to July 2018, 103 patients with ND-ENKTL were randomly assigned to SVILE (expe...

Full description

Bibliographic Details
Main Authors: Liqiang Wei, Lei Yang, Jin Ye, Jia Cong, Xin Li, Na Yao, Jing Yang, Xueying Cui, Jing Ding, Yiping Wu, Jingwen Wang
Format: Article
Language:English
Published: China Anti-Cancer Association 2020-08-01
Series:Cancer Biology & Medicine
Subjects:
extranodal natural killer/t-cell lymphoma
nasal type
chemotherapy
overall response
radiotherapy
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1684

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1684

Similar Items